Drug Information Association Logo
Corporate Tagline

Session 2 - FDA Updates

Track:
General Session

Day & Time:
January 13, 10:30AM - 12:00PM

Type:
Session

Title:
Session 2 - FDA Updates

Chair(s):
Gerald J. Dal Pan, MD
Director, Office of Surveillance and Epidemiology, CDER
FDA, United States

Description:
Session 2 - FDA Updates

Presentation(s) & Speaker(s):
Regulatory Updates from the FDA
Gerald J. Dal Pan, MD
Director, Office of Surveillance and Epidemiology, CDER
FDA, United States

Best Practices for Conducting and Reporting Pharmacoepidemiologic Safety Studies Using Electronic Health Care Data
Judy Anne Staffa, PhD,RPh
Director, Division of Epidemiology II, OPE, OSE , CDER
FDA , United States